デフォルト表紙
市場調査レポート
商品コード
1251996

中国伝統医薬:世界の慢性疾患の拡大が市場を牽引

Rising prevalence of chronic diseases across the globe is driving the traditional Chinese medicine market

出版日: | 発行: Persistence Market Research | ページ情報: 英文 193 Pages | 納期: 2~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
中国伝統医薬:世界の慢性疾患の拡大が市場を牽引
出版日: 2023年02月28日
発行: Persistence Market Research
ページ情報: 英文 193 Pages
納期: 2~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の中国伝統医薬の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、製品動向、価格分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

第3章 主要市場動向

  • 市場に影響を与える主要動向
  • 製品イノベーション・開発動向

第4章 主な成功要因

  • 製品採用・利用分析
  • 製品のUSP/機能
  • 最近の製品承認・発売
  • PESTLE分析
  • ポーターの分析
  • 規制シナリオ

第5章 市場の背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会分析

第6章 COVID-19危機:影響評価

第7章 世界市場の需要分析・予測

  • 過去の市場分析
  • 現在および将来の市場予測

第8章 世界市場の分析・予測:製品別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場分析・予測
    • 伝統中国医薬(TCM)
    • 非伝統中国医薬(非TCM)
  • 市場魅力度分析

第9章 世界市場の分析・予測:疾患別

  • イントロダクション/主な調査結果
  • 過去の市場分析
  • 現在および将来の市場分析・予測
    • 自閉症スペクトラム障害(ASD)
    • 注意欠陥多動性障害(ADHD)
  • 市場魅力度分析

第10章 世界市場の分析・予測:地域別

  • 過去の市場分析
  • 現在および将来の市場分析・予測
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力度分析

第11章 北米市場の分析・予測

第12章 ラテンアメリカ市場の分析・予測

第13章 欧州市場の分析・予測

第14章 南アジア市場の分析・予測

第15章 東アジア市場の分析・予測

第16章 オセアニア市場の分析・予測

第17章 中東・アフリカ市場の分析・予測

第18章 市場構造分析

  • 市場分析:企業ティア別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第19章 競合分析

  • 競合ダッシュボード
  • ブランディング&プロモーション戦略
  • 主な展開の分析
  • 競合ディープダイブ
    • Tongrentang
    • Zhongxin Pharmaceuticals
    • Tianjin Tasly Group
    • Yuannan Baiyao
    • Solstice Medicine Company, Inc.
    • Shanghai Sundise Traditional Chinese Medicine Co., Ltd
    • China Chinese Medicine Holding Co., Ltd.
    • Hunan goldliloo pharmaceutical Co., Ltd
    • Wanbang Pharma Group Corp.
    • Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
    • Pfizer Inc.
    • Eli Lilly and Company
    • Novartis AG
    • GlaxoSmithKline PLC
    • Mallinckrodt Pharmaceuticals
    • Hisamitsu Pharmaceutical Co., Inc.

第20章 仮定・頭字語

第21章 調査手法

図表

List of Tables

  • Table 01: Global Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Product, 2015-2022
  • Table 02: Global Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Product, 2023-2033
  • Table 03: Global Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Disease, 2015-2022
  • Table 04: Global Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Disease, 2023-2033
  • Table 05: Global Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Region 2015-2022
  • Table 06: Global Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Region, 2023-2033
  • Table 07: North America Traditional Chinese Medicine Market Historical Market Value (US$ Mn) Analysis, By Country, 2015-2022
  • Table 08: North America Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 09: North America Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Product, 2015-2022
  • Table 10: North America Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Product, 2023-2033
  • Table 11: North America Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Disease, 2015-2022
  • Table 12: North America Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Disease, 2023-2033
  • Table 13: Latin America Traditional Chinese Medicine Market Historical Market Value (US$ Mn) Analysis, By Country, 2015-2022
  • Table 14: Latin America Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 15: Latin America Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Product, 2015-2022
  • Table 16: Latin America Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Product, 2023-2033
  • Table 17: Latin America Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Disease, 2015-2022
  • Table 18: Latin America Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Disease, 2023-2033
  • Table 19: Europe Traditional Chinese Medicine Market Historical Market Value (US$ Mn) Analysis, By Country, 2015-2022
  • Table 20: Europe Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 21: Europe Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Product, 2015-2022
  • Table 22: Europe Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Product, 2023-2033
  • Table 23: Europe Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Disease, 2015-2022
  • Table 24: Europe Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Disease, 2023-2033
  • Table 25: South Asia Traditional Chinese Medicine Market Historical Market Value (US$ Mn) Analysis, By Country, 2015-2022
  • Table 26: South Asia Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 27: South Asia Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Product, 2015-2022
  • Table 28: South Asia Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Product, 2023-2033
  • Table 29: South Asia Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Disease, 2015-2022
  • Table 30: South Asia Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Disease, 2023-2033
  • Table 31: East Asia Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 32: East Asia Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 33: East Asia Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Product, 2015-2022
  • Table 34: East Asia Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Product, 2023-2033
  • Table 35: East Asia Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Disease, 2015-2022
  • Table 36: East Asia Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Disease, 2023-2033
  • Table 37: Oceania Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 38: Oceania Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 39: Oceania Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Product, 2015-2022
  • Table 40: Oceania Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Product, 2023-2033
  • Table 41: Oceania Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Disease, 2015-2022
  • Table 42: Oceania Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Disease, 2023-2033
  • Table 43: Middle East and Africa (MEA) Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 44: Middle East and Africa (MEA) Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Country, 2023-2033
  • Table 45: Middle East and Africa (MEA) Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Product, 2015-2022
  • Table 46: Middle East and Africa (MEA) Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Product, 2023-2033
  • Table 47: Middle East and Africa (MEA) Traditional Chinese Medicine Historical Market Value (US$ Mn) Analysis, By Disease, 2015-2022
  • Table 48: Middle East and Africa (MEA) Traditional Chinese Medicine Current and Future Market Size (US$ Mn) Analysis, By Disease, 2023-2033

List of Figures

  • Figure 01: Global Traditional Chinese Medicine Market (US$ Mn) Historical Analysis, 2015-2022
  • Figure 02: Global Traditional Chinese Medicine Market Value (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 03: Global Traditional Chinese Medicine Market Absolute $ Opportunity, 2023-2033
  • Figure 04: Global Traditional Chinese Medicine Market Share Analysis (%) By Product, 2023 & 2033
  • Figure 05: Global Traditional Chinese Medicine Market Y-o-Y Growth (%) By Product, 2023-2033
  • Figure 06: Global Traditional Chinese Medicine Market Attractiveness Analysis, By Product
  • Figure 07: Global Traditional Chinese Medicine Market Share Analysis (%) By Disease, 2023 & 2033
  • Figure 08: Global Traditional Chinese Medicine Market Y-o-Y Growth (%) By Disease, 2023-2033
  • Figure 09: Global Traditional Chinese Medicine Market Attractiveness Analysis, By Disease
  • Figure 10: Global Traditional Chinese Medicine Market Share Analysis (%) By Region, 2023 & 2033
  • Figure 11: Global Traditional Chinese Medicine Market Y-o-Y Growth (%) By Region, 2023-2033
  • Figure 12: Global Traditional Chinese Medicine Market Attractiveness Analysis, By Region
  • Figure 13: North America Traditional Chinese Medicine Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 14: North America Traditional Chinese Medicine Market Value (US$ Mn) Analysis, By Product, 2023
  • Figure 15: North America TRADITIONAL CHINESE MEDICINE Historical Market (US$ Mn) Analysis, 2015-2022
  • Figure 16: North America Traditional Chinese Medicine Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 17: North America Traditional Chinese Medicine Market Attractiveness Analysis, By Country
  • Figure 18: North America Traditional Chinese Medicine Market Attractiveness Analysis, By Product
  • Figure 19: North America Traditional Chinese Medicine Market Attractiveness Analysis, By Disease
  • Figure 20: U.S. Market Value Proportion Analysis, 2023
  • Figure 21: Global Vs U.S. Y-o-Y Growth Comparison, 2022-2033
  • Figure 22: U.S. Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 23: U.S. Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 24: Canada Market Value Proportion Analysis, 2023
  • Figure 25: Global Vs Canada Y-o-Y Growth Comparison, 2022-2033
  • Figure 26: Canada Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 27: Canada Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 28: Latin America Traditional Chinese Medicine Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 29: Latin America Traditional Chinese Medicine Market Value (US$ Mn) Analysis, By Product, 2023
  • Figure 30: Latin America Traditional Chinese Medicine Historical Market (US$ Mn) Analysis, 2015-2022
  • Figure 31: Latin America Traditional Chinese Medicine Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 32: Latin America Traditional Chinese Medicine Market Attractiveness Analysis, By Country
  • Figure 33: Latin America Traditional Chinese Medicine Market Attractiveness Analysis, By Product
  • Figure 34: Latin America Traditional Chinese Medicine Market Attractiveness Analysis, By Disease
  • Figure 35: Brazil Market Value Proportion Analysis, 2023
  • Figure 36: Global Vs Brazil Y-o-Y Growth Comparison, 2022-2033
  • Figure 37: Brazil Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 38: Brazil Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 39: Mexico Market Value Proportion Analysis, 2023
  • Figure 40: Global Vs Mexico Y-o-Y Growth Comparison, 2022-2033
  • Figure 41: Mexico Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 42: Mexico Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 43: Argentina Market Value Proportion Analysis, 2023
  • Figure 44: Global Vs Argentina Y-o-Y Growth Comparison, 2022-2033
  • Figure 45: Argentina Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 46: Argentina Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 47: Europe Traditional Chinese Medicine Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 48: Europe Traditional Chinese Medicine Market Value (US$ Mn) Analysis, By Product, 2023
  • Figure 49: Europe TRADITIONAL CHINESE MEDICINE Historical Market (US$ Mn) Analysis, 2015-2022
  • Figure 50: Europe Traditional Chinese Medicine Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 51: Europe Traditional Chinese Medicine Market Attractiveness Analysis, By Country
  • Figure 52: Europe Traditional Chinese Medicine Market Attractiveness Analysis, By Product
  • Figure 53: Europe Traditional Chinese Medicine Market Attractiveness Analysis, By Disease
  • Figure 54: U.K. Market Value Proportion Analysis, 2023
  • Figure 55: Global Vs U.K. Y-o-Y Growth Comparison, 2022-2033
  • Figure 56: U.K. Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 57: U.K. Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 58: Germany Market Value Proportion Analysis, 2023
  • Figure 59: Global Vs Germany Y-o-Y Growth Comparison, 2022-2033
  • Figure 60: Germany Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 61: Germany Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 62: Italy Market Value Proportion Analysis, 2023
  • Figure 63: Global Vs Italy Y-o-Y Growth Comparison, 2022-2033
  • Figure 64: Italy Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 65: Italy Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 66: France Market Value Proportion Analysis, 2023
  • Figure 67: Global Vs France Y-o-Y Growth Comparison, 2022-2033
  • Figure 68: France Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 69: France Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 70: Spain Market Value Proportion Analysis, 2023
  • Figure 71: Global Vs Spain Y-o-Y Growth Comparison, 2022-2033
  • Figure 72: Spain Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 73: Spain Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 74: Russia Market Value Proportion Analysis, 2023
  • Figure 75: Global Vs Russia Y-o-Y Growth Comparison, 2022-2033
  • Figure 76: Russia Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 77: Russia Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 78: Nordic Countries Market Value Proportion Analysis, 2023
  • Figure 79: Global Vs Nordic Countries Y-o-Y Growth Comparison, 2022-2033
  • Figure 80: Nordic Countries Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 81: Nordic Countries Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 82: BENELUX Market Value Proportion Analysis, 2023
  • Figure 83: Global Vs BENELUX Y-o-Y Growth Comparison, 2022-2033
  • Figure 84: BENELUX Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 85: BENELUX Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 86: South Asia Traditional Chinese Medicine Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 87: South Asia Traditional Chinese Medicine Market Value (US$ Mn) Analysis, By Product, 2023
  • Figure 88: South Asia TRADITIONAL CHINESE MEDICINE Historical Market (US$ Mn) Analysis, 2015-2022
  • Figure 89: South Asia Traditional Chinese Medicine Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 90: South Asia Traditional Chinese Medicine Market Attractiveness Analysis, By Country
  • Figure 91: South Asia Traditional Chinese Medicine Market Attractiveness Analysis, By Product
  • Figure 92: South Asia Traditional Chinese Medicine Market Attractiveness Analysis, By Disease
  • Figure 93: India Market Value Proportion Analysis, 2023
  • Figure 94: Global Vs India Y-o-Y Growth Comparison, 2022-2033
  • Figure 95: India Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 96: India Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 97: Thailand Market Value Proportion Analysis, 2023
  • Figure 98: Global Vs Thailand Y-o-Y Growth Comparison, 2022-2033
  • Figure 99: Thailand Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 100: Thailand Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 101: Indonesia Market Value Proportion Analysis, 2023
  • Figure 102: Global Vs Indonesia Y-o-Y Growth Comparison, 2022-2033
  • Figure 103: Indonesia Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 104: Indonesia Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 105: Malaysia Market Value Proportion Analysis, 2023
  • Figure 106: Global Vs Malaysia Y-o-Y Growth Comparison, 2022-2033
  • Figure 107: Malaysia Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 108: Malaysia Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 109: East Asia Traditional Chinese Medicine Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 110: East Asia Traditional Chinese Medicine Market Value (US$ Mn) Analysis, By Product, 2023
  • Figure 111: East Asia TRADITIONAL CHINESE MEDICINE Historical Market (US$ Mn) Analysis, 2015-2022
  • Figure 112: East Asia Traditional Chinese Medicine Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 113: East Asia Traditional Chinese Medicine Market Attractiveness Analysis, By Country
  • Figure 114: East Asia Traditional Chinese Medicine Market Attractiveness Analysis, By Product
  • Figure 115: East Asia Traditional Chinese Medicine Market Attractiveness Analysis, By Disease
  • Figure 116: China Market Value Proportion Analysis, 2023
  • Figure 117: Global Vs China Y-o-Y Growth Comparison, 2022-2033
  • Figure 118: China Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 119: China Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 120: Japan Market Value Proportion Analysis, 2023
  • Figure 121: Global Vs Japan Y-o-Y Growth Comparison, 2022-2033
  • Figure 122: Japan Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 123: Japan Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 124: South Korea Market Value Proportion Analysis, 2023
  • Figure 125: Global Vs South Korea Y-o-Y Growth Comparison, 2022-2033
  • Figure 126: South Korea Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 127: South Korea Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 128: Oceania Traditional Chinese Medicine Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 129: Oceania Traditional Chinese Medicine Market Value (US$ Mn) Analysis, By Product, 2023
  • Figure 130: Oceania TRADITIONAL CHINESE MEDICINE Historical Market (US$ Mn) Analysis, 2015-2022
  • Figure 131: Oceania Traditional Chinese Medicine Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 132: Oceania Traditional Chinese Medicine Market Attractiveness Analysis, By Country
  • Figure 133: Oceania Traditional Chinese Medicine Market Attractiveness Analysis, By Product
  • Figure 134: Oceania Traditional Chinese Medicine Market Attractiveness Analysis, By Disease
  • Figure 135: Australia Market Value Proportion Analysis, 2023
  • Figure 136: Global Vs Australia Y-o-Y Growth Comparison, 2022-2033
  • Figure 137: Australia Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 138: Australia Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 139: New Zealand Market Value Proportion Analysis, 2023
  • Figure 140: Global Vs New Zealand Y-o-Y Growth Comparison, 2022-2033
  • Figure 141: New Zealand Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 142: New Zealand Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 143: Middle East and Africa (Middle East and Africa (MEA)) Traditional Chinese Medicine Market Value (US$ Mn) Analysis, 2023 & 2033, by Country
  • Figure 144: Middle East and Africa (Middle East and Africa (MEA)) Traditional Chinese Medicine Market Value (US$ Mn) Analysis, By Product, 2023
  • Figure 145: Middle East and Africa (MEA) TRADITIONAL CHINESE MEDICINE Historical Market (US$ Mn) Analysis, 2015-2022
  • Figure 146: Middle East and Africa (MEA) Traditional Chinese Medicine Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2023-2033
  • Figure 147: Middle East and Africa (MEA) Traditional Chinese Medicine Market Attractiveness Analysis, By Country
  • Figure 148: Middle East and Africa (MEA) Traditional Chinese Medicine Market Attractiveness Analysis, By Product
  • Figure 149: Middle East and Africa (MEA) Traditional Chinese Medicine Market Attractiveness Analysis, By Disease
  • Figure 150: GCC Countries Market Value Proportion Analysis, 2023
  • Figure 151: Global Vs GCC Countries Y-o-Y Growth Comparison, 2022-2033
  • Figure 152: GCC Countries Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 153: GCC Countries Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 154: Turkiye Market Value Proportion Analysis, 2023
  • Figure 155: Global Vs Turkiye Y-o-Y Growth Comparison, 2022-2033
  • Figure 156: Turkiye Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 157: Turkiye Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 158: North Africa Market Value Proportion Analysis, 2023
  • Figure 159: Global Vs North Africa Y-o-Y Growth Comparison, 2022-2033
  • Figure 160: North Africa Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 161: North Africa Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 162: South Africa Market Value Proportion Analysis, 2023
  • Figure 163: Global Vs South Africa Y-o-Y Growth Comparison, 2022-2033
  • Figure 164: South Africa Traditional Chinese Medicine Market Share Analysis (%) By Product, 2022 & 2033
  • Figure 165: South Africa Traditional Chinese Medicine Market Share Analysis (%) by Disease, 2022 & 2033
目次
Product Code: PMRREP16219

Traditional Chinese Medicine Market: Scope of the Report

The latest publication by Persistence Market Research on the global traditional Chinese medicine market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for traditional Chinese medicine products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the traditional Chinese medicine market. Shareholders in the traditional Chinese medicine market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the traditional Chinese medicine market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the traditional Chinese medicine market offers information divided into three important segments - product, disease, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Traditional Chinese Medicine (TCM)

Autism Spectrum Disorder (ASD)

Attention Deficit Hyperactivity Disorder (ADHD)

Non-Traditional Chinese Medicine (Non-TCM)

Autism Spectrum Disorder (ASD)

Attention Deficit Hyperactivity Disorder (ADHD)

Disease

Autism Spectrum Disorder (ASD)

Attention Deficit Hyperactivity Disorder (ADHD)

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for traditional Chinese medicine over the coming years?

How will changing trends influence the market?

How has the COVID-19 crisis influenced market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will influence the market?

How can companies in the traditional Chinese medicine market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the traditional Chinese medicine market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the traditional Chinese medicine market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption / Usage Analysis
  • 4.2. Product USPs / Features
  • 4.3. Recent Product Approval and Launches
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Regulatory Scenario

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Herbal Medicine Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Adoption Of TCM
    • 5.2.2. Massive Infrastructure Planning for Global Manufacturing
    • 5.2.3. Favourable Regulatory and Reimbursement Scenario
    • 5.2.4. Increasing Research and Development
    • 5.2.5. Growth of Top Companies
    • 5.2.6. Mergers and Acquisitions
    • 5.2.7. Increasing Incidence of Lifestyle Diseases
  • 5.3. Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Disease
    • 6.1.3. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2015-2022 and Forecast 2023-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2015-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2023-2033
    • 8.3.1. Traditional Chinese Medicine (TCM)
      • 8.3.1.1. Autism Spectrum Disorder (ASD)
      • 8.3.1.2. Attention Deficit Hyperactivity Disorder (ADHD)
    • 8.3.2. Non-Traditional Chinese Medicine (Non-TCM)
      • 8.3.2.1. Autism Spectrum Disorder (ASD)
      • 8.3.2.2. Attention Deficit Hyperactivity Disorder (ADHD)
  • 8.4. Market Attractiveness Analysis By Product

9. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Disease

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Disease, 2015-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2023-2033
    • 9.3.1. Autism Spectrum Disorder (ASD)
    • 9.3.2. Attention Deficit Hyperactivity Disorder (ADHD)
  • 9.4. Market Attractiveness Analysis By Disease

10. Global Market Analysis 2015-2022 and Forecast 2023-2033, by Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. South Asia
    • 10.3.5. East Asia
    • 10.3.6. Oceania
    • 10.3.7. Middle East and Africa (Middle East and Africa (MEA))
  • 10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2015-2022 and Forecast 2023-2033

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 11.3.1. By Country
      • 11.3.1.1. U.S.
      • 11.3.1.2. Canada
    • 11.3.2. By Product
    • 11.3.3. By Disease
  • 11.4. Market Attractiveness Analysis
    • 11.4.1. By Country
    • 11.4.2. By Product
    • 11.4.3. By Disease
  • 11.5. Country Level Analysis & Forecast
    • 11.5.1. U.S. Market Analysis
      • 11.5.1.1. Introduction
      • 11.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 11.5.1.2.1. By Product
        • 11.5.1.2.2. By Disease
    • 11.5.2. Canada Market Analysis
      • 11.5.2.1. Introduction
      • 11.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 11.5.2.2.1. By Product
        • 11.5.2.2.2. By Disease
  • 11.6. Market Trends
  • 11.7. Key Market Participants - Intensity Mapping
  • 11.8. Drivers and Restraints - Impact Analysis

12. Latin America Market Analysis 2015-2022 and Forecast 2023-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 12.3.1. By Country
      • 12.3.1.1. Brazil
      • 12.3.1.2. Mexico
      • 12.3.1.3. Argentina
      • 12.3.1.4. Rest of Latin America
    • 12.3.2. By Disease
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Disease
  • 12.5. Country Level Analysis & Forecast
    • 12.5.1. Brazil Market Analysis
      • 12.5.1.1. Introduction
      • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.1.2.1. By Product
        • 12.5.1.2.2. By Disease
    • 12.5.2. Mexico Market Analysis
      • 12.5.2.1. Introduction
      • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.2.2.1. By Product
        • 12.5.2.2.2. By Disease
    • 12.5.3. Argentina Market Analysis
      • 12.5.3.1. Introduction
      • 12.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 12.5.3.2.1. By Product
        • 12.5.3.2.2. By Disease
  • 12.6. Market Trends
  • 12.7. Key Market Participants - Intensity Mapping
  • 12.8. Drivers and Restraints - Impact Analysis

13. Europe Market Analysis 2015-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Market Taxonomy, 2023-2033
    • 13.3.1. By Country
      • 13.3.1.1. Germany
      • 13.3.1.2. France
      • 13.3.1.3. Italy
      • 13.3.1.4. U.K.
      • 13.3.1.5. Spain
      • 13.3.1.6. Russia
      • 13.3.1.7. BENELUX
      • 13.3.1.8. Nordic Countries
      • 13.3.1.9. Rest of Europe
    • 13.3.2. By Product
    • 13.3.3. By Disease
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Disease
  • 13.5. Country Level Analysis & Forecast
    • 13.5.1. Germany Market Analysis
      • 13.5.1.1. Introduction
      • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.1.2.1. By Product
        • 13.5.1.2.2. By Disease
    • 13.5.2. France Market Analysis
      • 13.5.2.1. Introduction
      • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.2.2.1. By Product
        • 13.5.2.2.2. By Disease
    • 13.5.3. Italy Market Analysis
      • 13.5.3.1. Introduction
      • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.3.2.1. By Product
        • 13.5.3.2.2. By Disease
    • 13.5.4. U.K. Market Analysis
      • 13.5.4.1. Introduction
      • 13.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.4.2.1. By Product
        • 13.5.4.2.2. By Disease
    • 13.5.5. Spain Market Analysis
      • 13.5.5.1. Introduction
      • 13.5.5.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.5.2.1. By Product
        • 13.5.5.2.2. By Disease
    • 13.5.6. Russia Market Analysis
      • 13.5.6.1. Introduction
      • 13.5.6.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.6.2.1. By Product
        • 13.5.6.2.2. By Disease
    • 13.5.7. Nordic Countries Market Analysis
      • 13.5.7.1. Introduction
      • 13.5.7.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.7.2.1. By Product
        • 13.5.7.2.2. By Disease
    • 13.5.8. BENELUX Market Analysis
      • 13.5.8.1. Introduction
      • 13.5.8.2. Market Analysis and Forecast by Market Taxonomy
        • 13.5.8.2.1. By Product
        • 13.5.8.2.2. By Disease
  • 13.6. Market Trends
  • 13.7. Key Market Participants - Intensity Mapping
  • 13.8. Drivers and Restraints - Impact Analysis

14. South Asia Market Analysis 2015-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. India
      • 14.3.1.2. Thailand
      • 14.3.1.3. Indonesia
      • 14.3.1.4. Malaysia
      • 14.3.1.5. Rest of South Asia
    • 14.3.2. By Product
    • 14.3.3. By Disease
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Disease
  • 14.5. Country Level Analysis & Forecast
    • 14.5.1. India Market Analysis
      • 14.5.1.1. Introduction
      • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.1.2.1. By Product
        • 14.5.1.2.2. By Disease
    • 14.5.2. Thailand Market Analysis
      • 14.5.2.1. Introduction
      • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.2.2.1. By Product
        • 14.5.2.2.2. By Disease
    • 14.5.3. Indonesia Market Analysis
      • 14.5.3.1. Introduction
      • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.3.2.1. By Product
        • 14.5.3.2.2. By Disease
    • 14.5.4. Malaysia Market Analysis
      • 14.5.4.1. Introduction
      • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 14.5.4.2.1. By Product
        • 14.5.4.2.2. By Disease
  • 14.6. Market Trends
  • 14.7. Key Market Participants - Intensity Mapping
  • 14.8. Drivers and Restraints - Impact Analysis

15. East Asia Market Analysis 2015-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. China
      • 15.3.1.2. Japan
      • 15.3.1.3. South Korea
    • 15.3.2. By Product
    • 15.3.3. By Disease
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Disease
  • 15.5. Country Level Analysis & Forecast
    • 15.5.1. China Market Analysis
      • 15.5.1.1. Introduction
      • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.1.2.1. By Product
        • 15.5.1.2.2. By Disease
    • 15.5.2. Japan Market Analysis
      • 15.5.2.1. Introduction
      • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.2.2.1. By Product
        • 15.5.2.2.2. By Disease
    • 15.5.3. South Korea Market Analysis
      • 15.5.3.1. Introduction
      • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.5.3.2.1. By Product
        • 15.5.3.2.2. By Disease
  • 15.6. Market Trends
  • 15.7. Key Market Participants - Intensity Mapping
  • 15.8. Drivers and Restraints - Impact Analysis

16. Oceania Market Analysis 2015-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. Australia
      • 16.3.1.2. New Zealand
    • 16.3.2. By Product
    • 16.3.3. By Disease
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Disease
  • 16.5. Country Level Analysis & Forecast
    • 16.5.1. Australia Market Analysis
      • 16.5.1.1. Introduction
      • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.1.2.1. By Product
        • 16.5.1.2.2. By Disease
    • 16.5.2. New Zealand Market Analysis
      • 16.5.2.1. Introduction
      • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.5.2.2.1. By Product
        • 16.5.2.2.2. By Disease
  • 16.6. Market Trends
  • 16.7. Key Market Participants - Intensity Mapping
  • 16.8. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Market Analysis 2015-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2022
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. GCC Countries
      • 17.3.1.2. Turkiye
      • 17.3.1.3. Northern Africa
      • 17.3.1.4. South Africa
      • 17.3.1.5. Rest of Middle East and Africa
    • 17.3.2. By Product
    • 17.3.3. By Disease
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Disease
  • 17.5. Country Level Analysis & Forecast
    • 17.5.1. GCC Countries Market Analysis
      • 17.5.1.1. Introduction
      • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.1.2.1. By Product
        • 17.5.1.2.2. By Disease
    • 17.5.2. Turkiye Market Analysis
      • 17.5.2.1. Introduction
      • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.2.2.1. By Product
        • 17.5.2.2.2. By Disease
    • 17.5.3. Northern Africa Market Analysis
      • 17.5.3.1. Introduction
      • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.3.2.1. By Product
        • 17.5.3.2.2. By Disease
    • 17.5.4. South Africa Market Analysis
      • 17.5.4.1. Introduction
      • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.5.4.2.1. By Product
        • 17.5.4.2.2. By Disease
  • 17.6. Market Trends
  • 17.7. Key Market Participants - Intensity Mapping
  • 17.8. Drivers and Restraints - Impact Analysis

18. Market Structure Analysis

  • 18.1. Market Analysis by Tier of Companies
  • 18.2. Market Share Analysis of Top Players
  • 18.3. Market Presence Analysis

19. Competition Analysis

  • 19.1. Competition Dashboard
  • 19.2. Branding and Promotional Strategies
  • 19.3. Key Development Analysis
  • 19.4. Competition Deep Dive
    • 19.4.1. Tongrentang
      • 19.4.1.1. Overview
      • 19.4.1.2. Product Portfolio
      • 19.4.1.3. Key Financials
      • 19.4.1.4. Sales Footprint
      • 19.4.1.5. SWOT Analysis
      • 19.4.1.6. Strategy Overview
        • 19.4.1.6.1. Marketing Strategy
        • 19.4.1.6.2. Product Strategy
        • 19.4.1.6.3. Channel Strategy
    • 19.4.2. Zhongxin Pharmaceuticals
      • 19.4.2.1. Overview
      • 19.4.2.2. Product Portfolio
      • 19.4.2.3. Key Financials
      • 19.4.2.4. Sales Footprint
      • 19.4.2.5. SWOT Analysis
      • 19.4.2.6. Strategy Overview
        • 19.4.2.6.1. Marketing Strategy
        • 19.4.2.6.2. Product Strategy
        • 19.4.2.6.3. Channel Strategy
    • 19.4.3. Tianjin Tasly Group
      • 19.4.3.1. Overview
      • 19.4.3.2. Product Portfolio
      • 19.4.3.3. Key Financials
      • 19.4.3.4. Sales Footprint
      • 19.4.3.5. SWOT Analysis
      • 19.4.3.6. Strategy Overview
        • 19.4.3.6.1. Marketing Strategy
        • 19.4.3.6.2. Product Strategy
        • 19.4.3.6.3. Channel Strategy
    • 19.4.4. Yuannan Baiyao
      • 19.4.4.1. Overview
      • 19.4.4.2. Product Portfolio
      • 19.4.4.3. Key Financials
      • 19.4.4.4. Sales Footprint
      • 19.4.4.5. SWOT Analysis
      • 19.4.4.6. Strategy Overview
        • 19.4.4.6.1. Marketing Strategy
        • 19.4.4.6.2. Product Strategy
        • 19.4.4.6.3. Channel Strategy
    • 19.4.5. Solstice Medicine Company, Inc.
      • 19.4.5.1. Overview
      • 19.4.5.2. Product Portfolio
      • 19.4.5.3. Key Financials
      • 19.4.5.4. Sales Footprint
      • 19.4.5.5. SWOT Analysis
      • 19.4.5.6. Strategy Overview
        • 19.4.5.6.1. Marketing Strategy
        • 19.4.5.6.2. Product Strategy
        • 19.4.5.6.3. Channel Strategy
    • 19.4.6. Shanghai Sundise Traditional Chinese Medicine Co., Ltd
      • 19.4.6.1. Overview
      • 19.4.6.2. Product Portfolio
      • 19.4.6.3. Key Financials
      • 19.4.6.4. Sales Footprint
      • 19.4.6.5. SWOT Analysis
      • 19.4.6.6. Strategy Overview
        • 19.4.6.6.1. Marketing Strategy
        • 19.4.6.6.2. Product Strategy
        • 19.4.6.6.3. Channel Strategy
    • 19.4.7. China Chinese Medicine Holding Co., Ltd.
      • 19.4.7.1. Overview
      • 19.4.7.2. Product Portfolio
      • 19.4.7.3. Key Financials
      • 19.4.7.4. Sales Footprint
      • 19.4.7.5. SWOT Analysis
      • 19.4.7.6. Strategy Overview
        • 19.4.7.6.1. Marketing Strategy
        • 19.4.7.6.2. Product Strategy
        • 19.4.7.6.3. Channel Strategy
    • 19.4.8. Hunan goldliloo pharmaceutical Co., Ltd
      • 19.4.8.1. Overview
      • 19.4.8.2. Product Portfolio
      • 19.4.8.3. Key Financials
      • 19.4.8.4. Sales Footprint
      • 19.4.8.5. SWOT Analysis
      • 19.4.8.6. Strategy Overview
        • 19.4.8.6.1. Marketing Strategy
        • 19.4.8.6.2. Product Strategy
        • 19.4.8.6.3. Channel Strategy
    • 19.4.9. Wanbang Pharma Group Corp.
      • 19.4.9.1. Overview
      • 19.4.9.2. Product Portfolio
      • 19.4.9.3. Key Financials
      • 19.4.9.4. Sales Footprint
      • 19.4.9.5. SWOT Analysis
      • 19.4.9.6. Strategy Overview
        • 19.4.9.6.1. Marketing Strategy
        • 19.4.9.6.2. Product Strategy
        • 19.4.9.6.3. Channel Strategy
    • 19.4.10. Chengdu Qiankun Veterinary Pharmaceuticals Co., Ltd.
      • 19.4.10.1. Overview
      • 19.4.10.2. Product Portfolio
      • 19.4.10.3. Key Financials
      • 19.4.10.4. Sales Footprint
      • 19.4.10.5. SWOT Analysis
      • 19.4.10.6. Strategy Overview
        • 19.4.10.6.1. Marketing Strategy
        • 19.4.10.6.2. Product Strategy
        • 19.4.10.6.3. Channel Strategy
    • 19.4.11. Pfizer Inc.
      • 19.4.11.1. Overview
      • 19.4.11.2. Product Portfolio
      • 19.4.11.3. Key Financials
      • 19.4.11.4. Sales Footprint
      • 19.4.11.5. SWOT Analysis
      • 19.4.11.6. Strategy Overview
        • 19.4.11.6.1. Marketing Strategy
        • 19.4.11.6.2. Product Strategy
        • 19.4.11.6.3. Channel Strategy
    • 19.4.12. Eli Lilly and Company
      • 19.4.12.1. Overview
      • 19.4.12.2. Product Portfolio
      • 19.4.12.3. Key Financials
      • 19.4.12.4. Sales Footprint
      • 19.4.12.5. SWOT Analysis
      • 19.4.12.6. Strategy Overview
        • 19.4.12.6.1. Marketing Strategy
        • 19.4.12.6.2. Product Strategy
        • 19.4.12.6.3. Channel Strategy
    • 19.4.13. Novartis AG
      • 19.4.13.1. Overview
      • 19.4.13.2. Product Portfolio
      • 19.4.13.3. Key Financials
      • 19.4.13.4. Sales Footprint
      • 19.4.13.5. SWOT Analysis
      • 19.4.13.6. Strategy Overview
        • 19.4.13.6.1. Marketing Strategy
        • 19.4.13.6.2. Product Strategy
        • 19.4.13.6.3. Channel Strategy
    • 19.4.14. GlaxoSmithKline PLC
      • 19.4.14.1. Overview
      • 19.4.14.2. Product Portfolio
      • 19.4.14.3. Key Financials
      • 19.4.14.4. Sales Footprint
      • 19.4.14.5. SWOT Analysis
      • 19.4.14.6. Strategy Overview
        • 19.4.14.6.1. Marketing Strategy
        • 19.4.14.6.2. Product Strategy
        • 19.4.14.6.3. Channel Strategy
    • 19.4.15. Mallinckrodt Pharmaceuticals
      • 19.4.15.1. Overview
      • 19.4.15.2. Product Portfolio
      • 19.4.15.3. Key Financials
      • 19.4.15.4. Sales Footprint
      • 19.4.15.5. SWOT Analysis
      • 19.4.15.6. Strategy Overview
        • 19.4.15.6.1. Marketing Strategy
        • 19.4.15.6.2. Product Strategy
        • 19.4.15.6.3. Channel Strategy
    • 19.4.16. Hisamitsu Pharmaceutical Co., Inc.
      • 19.4.16.1. Overview
      • 19.4.16.2. Product Portfolio
      • 19.4.16.3. Key Financials
      • 19.4.16.4. Sales Footprint
      • 19.4.16.5. SWOT Analysis
      • 19.4.16.6. Strategy Overview
        • 19.4.16.6.1. Marketing Strategy
        • 19.4.16.6.2. Product Strategy
        • 19.4.16.6.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology